P2.05 Arterial Wall Function in Patients with Coronary Heart Disease and Dyslipidemia, Comparative Efficacy of Ezetimibe, Statins and Their Combination
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
P2.05 Arterial Wall Function in Patients with Coronary Heart Disease and Dyslipidemia, Comparative Efficacy of Ezetimibe, Statins and Their Combination ; volume:4 ; number:4 ; day:2 ; month:12 ; year:2010 ; pages:157-158 ; date:12.2010
Artery research ; 4, Heft 4 (2.12.2010), 157-158, 12.2010
- Creator
-
Tripoten, M. I.
Pogorelova, O. A.
Zubareva, M. Y.
Kukharchuk, V. V.
Rogoza, A. N.
Susekov, A. V.
Balakhonova, T. V.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1016/j.artres.2010.10.038
- URN
-
urn:nbn:de:101:1-2405021314289.553783623864
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tripoten, M. I.
- Pogorelova, O. A.
- Zubareva, M. Y.
- Kukharchuk, V. V.
- Rogoza, A. N.
- Susekov, A. V.
- Balakhonova, T. V.
- SpringerLink (Online service)
Other Objects (12)
Safety of Prescribing Statins in Childhood Dyslipidemia
The role of dyslipidemia and statins in venous thromboembolism
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Coronary arterial fistulas
Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes
P1.33 Predictors of Arterial Markers in Metabolic Syndrome Patients: Arterial Hypertension and Gender Outbid Dyslipidemia
Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
Tiny ruptured coronary aneurysm with coronary-pulmonary arterial fistula
Diabetes Dyslipidemia
Statins in Females
Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease
Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III
Safety of Prescribing Statins in Childhood Dyslipidemia
The role of dyslipidemia and statins in venous thromboembolism
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Coronary arterial fistulas
Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes
P1.33 Predictors of Arterial Markers in Metabolic Syndrome Patients: Arterial Hypertension and Gender Outbid Dyslipidemia
Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
Tiny ruptured coronary aneurysm with coronary-pulmonary arterial fistula
Diabetes Dyslipidemia
Statins in Females
Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease
Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III
Safety of Prescribing Statins in Childhood Dyslipidemia
The role of dyslipidemia and statins in venous thromboembolism
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
Coronary arterial fistulas
Combination therapy analysis of ezetimibe and statins in Chinese patients with acute coronary syndrome and type 2 diabetes
P1.33 Predictors of Arterial Markers in Metabolic Syndrome Patients: Arterial Hypertension and Gender Outbid Dyslipidemia
Effect of statins on coronary blood flow after percutaneous coronary intervention in patients with stable coronary artery disease
Tiny ruptured coronary aneurysm with coronary-pulmonary arterial fistula
Diabetes Dyslipidemia
Statins in Females
Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease